Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
---|
09/28/2005 | EP1580269A1 Method of detecting gene mutation |
09/28/2005 | EP1580262A1 Method for producing L-amino acid |
09/28/2005 | EP1579212A2 Methods of identifying reduced internalization transmembrane receptor agonists |
09/28/2005 | EP1578952A2 Direct snp detection with unamplified dna |
09/28/2005 | EP1578945A2 Cct6s as modifiers of the rb pathway and methods of use |
09/28/2005 | EP1578940A2 Methods and compositions for diagnosing dysplasia |
09/28/2005 | EP1578932A2 Synthetic tag genes |
09/28/2005 | EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes |
09/28/2005 | EP1578918A2 Atherosclerotic phenotype determinative genes and methods for using the same |
09/28/2005 | EP1578914A2 Human ion channels |
09/28/2005 | EP1578761A2 Structural motifs and oligomeric compounds and their use in gene modulation |
09/28/2005 | EP1578192A2 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
09/28/2005 | CN1675378A Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid |
09/28/2005 | CN1673351A Short lactobacillus producing gamma-aminobutyric acid and use thereof |
09/28/2005 | CN1673349A Lilacinus pseudo-blue mold new strain and process for preparing nematicide with shrimp shell thereof |
09/28/2005 | CN1220774C PCR method |
09/28/2005 | CN1220770C Broad spectrum bacillus thuringiensis and the method for preparing pesticide therewith |
09/27/2005 | US6949206 Organic species that facilitate charge transfer to or from nanostructures |
09/22/2005 | WO2005038006A8 Chimeric metabotropic glutamate receptors and uses thereof |
09/22/2005 | WO2005021734A3 Generation of hematopoietic chimerism and induction of central tolerance |
09/22/2005 | WO2005014786A3 Enhanced engineered chromosome formation from alpha satellite with artificially increased density of cenp-b boxes |
09/22/2005 | WO2004096995A3 Recombinant plant dicer |
09/22/2005 | WO2004044178A3 Methods and compositions for diagnosing dysplasia |
09/22/2005 | US20050210541 Using sperm adhesion molecule 1 (SPAM 1) as tool to enhance sperm attachment to egg; in vitro fertilization |
09/22/2005 | US20050208580 Novel protein and method for producing the protein |
09/22/2005 | US20050208530 Using recombination reaction, primer extension and dideoxynucleotides to sequence all or part of a nucleic acid segment |
09/22/2005 | US20050208526 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening |
09/22/2005 | US20050208468 Assays with primary cells |
09/22/2005 | US20050205850 Organic species that facilitate charge transfer to or from nanostructures |
09/22/2005 | US20050205849 Addition polymer modified with amine, mercaptan, phosphorus compound or acid compound |
09/21/2005 | EP1577389A2 Magnetic pigment |
09/21/2005 | EP1576151A2 Ap1 amine oxidase variants |
09/21/2005 | EP1576150A2 Methods and compositions for increasing the efficacy of biologically-active ingredients |
09/21/2005 | EP1576146A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
09/21/2005 | EP1576123A2 Process for the biological production of 1,3-propanediol with high yield |
09/21/2005 | EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
09/21/2005 | EP1576089A2 Expansion of renewable stem cell populations |
09/21/2005 | EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
09/21/2005 | EP1575993A2 Methods for treating patients and identifying therapeutics |
09/21/2005 | EP1575484A2 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
09/21/2005 | EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
09/21/2005 | CN1671420A Pegylated factor VII glycoforms |
09/21/2005 | CN1670184A Peptides natural microbial antiseptic agent producing strain, its use and preparation method for antiseptic agent |
09/21/2005 | CN1670182A Vanillin strain prepared by microbial conversion and method thereof |
09/21/2005 | CN1219884C Construction of lactobacillus acidophilus lethal-balance gene expression system |
09/21/2005 | CN1219879C Hainan variety of lilac grey streptomycete and method for preparing agricultural antibiotic from variety |
09/21/2005 | CN1219878C Gordona nitida and application of removing sulfur element from sulfur compound |
09/21/2005 | CN1219877C Streptomyces ces virdocyaneus sp nov |
09/21/2005 | CN1219876C Streptomycete albogriseus spnov |
09/15/2005 | WO2005056759A3 Methods of generating variant proteins with increased host string content and compositions thereof |
09/15/2005 | WO2005054430A3 Hepatitis c virus inhibitors |
09/15/2005 | WO2005052127A3 Real-time detection of nucleic acids and proteins |
09/15/2005 | WO2005052118A3 Method for identifying androgen receptor modulators with full or mixed agonist activity |
09/15/2005 | WO2005044999A3 Treatment with immunoregulatory t cells |
09/15/2005 | WO2005044982A3 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
09/15/2005 | WO2005038001A3 Improved transgenesis by sperm-mediated gene transfer |
09/15/2005 | WO2005033268A9 Stem cells for clinical and commercial uses |
09/15/2005 | WO2005026323A3 Stationary phases and a purification process using the stationary phases |
09/15/2005 | WO2005014777A3 Methods and compositions for increasing the efficacy of biologically-active ingredients |
09/15/2005 | WO2005012499A3 Methods for amplifying polymeric nucleic acids |
09/15/2005 | WO2005012496A3 Novel nucleic acids from sesame plants |
09/15/2005 | WO2005012482A3 Assay for identification of bioactive compounds that interact with heat shock protein 90 |
09/15/2005 | WO2005010151A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
09/15/2005 | WO2005005611A3 Crystals and structures of protein kinase chk2 |
09/15/2005 | WO2005001022A3 Methods and compositions for enhancing immune response |
09/15/2005 | WO2004111200A3 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer |
09/15/2005 | WO2004111188A3 Process for the treatment of chitinaceous materials and for the deacetylation of chitin |
09/15/2005 | WO2004096997A3 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
09/15/2005 | WO2004094606A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2 |
09/15/2005 | US20050202543 Method for producing L-amino acid |
09/15/2005 | US20050202529 Humanised antibodies |
09/15/2005 | US20050202441 Methods of designing, synthesizing, and propagating reference nucleic acids |
09/15/2005 | US20050202417 Oligonucleotide probe for determining concentration of viral genomes in biological fluids |
09/14/2005 | EP1573070A2 pRNA CHIMERA |
09/14/2005 | EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
09/14/2005 | EP1573009A2 Detection of small nucleic acids |
09/14/2005 | EP1572978A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
09/14/2005 | EP1572977A2 Assay and compositions for detection of bacillus anthracis nucleic acid |
09/14/2005 | EP1572974A2 Polynucleotide sequence detection assays and analysis |
09/14/2005 | EP1572962A2 Bioinformatically detectable group of novel regulatory genes and uses thereof |
09/14/2005 | EP1572948A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
09/14/2005 | EP1572932A2 Reagents and methods for identifying and modulating expression of tumor senescence genes |
09/14/2005 | EP1572928A2 Plant acyl-coa synthetases |
09/14/2005 | EP1572910A2 Signal for packaging of influenza virus vectors |
09/14/2005 | EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
09/14/2005 | EP1572881A2 Tacis and br3 polypeptides and uses thereof |
09/14/2005 | EP1572876A2 Transcriptional regulation of target genes |
09/14/2005 | EP0833933B1 A vector and method for producing influenza hemagglutinin |
09/14/2005 | CN1668187A Transgenic ungulates capable of human antibody production |
09/13/2005 | US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
09/13/2005 | US6942853 Latent fusion protein |
09/09/2005 | WO2005059156A3 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used |
09/09/2005 | WO2005056765A3 Methods for culturing keratinocytes from human embryonic stem cells |
09/09/2005 | WO2005047483A3 Renta: an hiv immunogen and uses thereof |
09/09/2005 | WO2005047481A3 Novel sequences encoding hapatitis c virus glycoproteins |
09/09/2005 | WO2005044996A3 Chimeric receptors with 4-1bb stimulatory signaling domain |
09/09/2005 | WO2005042714A3 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
09/09/2005 | WO2005042692A3 A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors |
09/09/2005 | WO2005035721A3 Native immunoglobulin binding reagents and methods for making and using same |
09/09/2005 | WO2005033265A3 Optimized multi-epitope constructs and uses thereof |